FDA Committee Recommends Approval of Opioid Withdrawal Drug

By Sam | March 27, 2018

The Psychopharmacologic Drugs Advisory Committee voted to recommend approval of an NDA for lofexidine hydrochloride for mitigation of opioid withdrawal symptoms.
Source: Drug Industry Daily

Posted in Drug Industry Daily